Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Montiel

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 5, 2021
Prevention of incisional hernia with a reinforced tension line (RTL) versus primary suture only in midline laparotomies: 3-year follow-up in a randomized clinical trialE E Lozada-Hernández, J C Mayagoitía-González, R L Smolinski-Kurek, et al.
Bone Marrow Transplantation|June 13, 2000
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilizationJ Vela-Ojeda, F Tripp-Villanueva, L Montiel-Cervantes, et al.
Revista De Neurologia|June 9, 2007
[Impact of warning against procrastination of thrombolysis in ischemic stroke]J F Maestre-Moreno, C Arnáiz-Urrutia, P del Saz-Saucedo, et al.
Salud Publica De Mexico|May 1, 1994
[Maternal mortality in the Huichol area of Jalisco state, Mexico. The Study Group on Maternal Mortality]J Blanco Muñoz, R Hernández Muñoz, A L Montiel Cervantes, et al.
Annals of Hematology|August 20, 2002
Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemiaJ Vela-Ojeda, M A García-Ruiz Esparza, A Rosas-Cabral, et al.
Annals of Hematology|November 29, 2005
Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantationJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Annals of Hematology|March 10, 2006
Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myelomaJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Stem Cells and Development|June 23, 2005
CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donorsJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Stem Cells and Development|December 14, 2004
Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemiaJ Vela-Ojeda, M A García-Ruiz Esparza, F Tripp-Villanueva, et al.
Annals of Hematology|April 3, 2004
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3(+) and CD4(+) lymphocytesJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 5, 2021
Prevention of incisional hernia with a reinforced tension line (RTL) versus primary suture only in midline laparotomies: 3-year follow-up in a randomized clinical trialE E Lozada-Hernández, J C Mayagoitía-González, R L Smolinski-Kurek, et al.
Bone Marrow Transplantation|June 13, 2000
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilizationJ Vela-Ojeda, F Tripp-Villanueva, L Montiel-Cervantes, et al.
Revista De Neurologia|June 9, 2007
[Impact of warning against procrastination of thrombolysis in ischemic stroke]J F Maestre-Moreno, C Arnáiz-Urrutia, P del Saz-Saucedo, et al.
Salud Publica De Mexico|May 1, 1994
[Maternal mortality in the Huichol area of Jalisco state, Mexico. The Study Group on Maternal Mortality]J Blanco Muñoz, R Hernández Muñoz, A L Montiel Cervantes, et al.
Annals of Hematology|August 20, 2002
Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemiaJ Vela-Ojeda, M A García-Ruiz Esparza, A Rosas-Cabral, et al.
Annals of Hematology|November 29, 2005
Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantationJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Annals of Hematology|March 10, 2006
Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myelomaJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Stem Cells and Development|June 23, 2005
CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donorsJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Stem Cells and Development|December 14, 2004
Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemiaJ Vela-Ojeda, M A García-Ruiz Esparza, F Tripp-Villanueva, et al.
Annals of Hematology|April 3, 2004
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3(+) and CD4(+) lymphocytesJ Vela-Ojeda, M A García-Ruiz Esparza, E Reyes-Maldonado, et al.
Pageof 6